UCC
Alpaca Bio is building a platform of antibody-derived immunopeptides with broad-spectrum, immune-boosting antimicrobial activity. These safe molecules act rapidly, break resistance, and synergize with standard therapies. Starting with a breakthrough treatment for Recurrent Vulvovaginal Candidiasis (RVVC), we aim to expand across infectious diseases with high unmet need.
Last Updated:
Last Updated:
To complement excellence in scientific research, successful commercialisation requires research teams to have a strong understanding of their target markets, the specific problems their technologies address, the competitive landscape, and the ability to...
On December 3rd, 2025, we marked a major milestone for Ireland’s therapeutics ecosystem. The launch of the ARC Hub for Therapeutics was an energising and inspiring day, bringing together a brilliant community of academics, investors, funders, policymakers, and...
